Scimago Lab
powered by Scopus
eISSN: 1941-5923
call: +1.631.629.4328
Mon-Fri 10 am - 2 pm EST


Medical Science Monitor Basic Research


Epidermolysis Bullosa Acquisita: A Case Report

Challenging differential diagnosis, Rare disease

Erik A. Kumetz, Jon H. Meyerle, Shayna C. Rivard

Guam Department of Flight Medicine, 36th Medical Group, Andersen Air Force Base, Yigo, Guam

Am J Case Rep 2020; 21:e919432

DOI: 10.12659/AJCR.919432

Available online: 2020-03-23

Published: 2020-04-20


BACKGROUND: Epidermolysis bullosa acquisita is a rare, subepithelial bullous disorder, which is distinguished from other autoimmune blistering diseases by the production of antibodies against type VII collagen.
CASE REPORT: Here, we describe the case of a 79-year-old male resident of the Northern Mariana Islands who presented to the clinic with multiple blistering skin lesions.
CONCLUSIONS: The primary focus of treatment is to prevent disease progression and serious complications of scarring (including blindness and respiratory obstruction) by avoiding physical trauma and suppressing the immune systems with agents, including corticosteroids, colchicine, dapsone, methotrexate, and cyclophosphamide. Successful treatment of the condition should involve a multidisciplinary team of medical professionals with regular monthly follow-ups during periods of active disease.

Keywords: Collagen Type VII, Epidermolysis Bullosa Acquisita, Micronesia